Treatment of Graves’ disease with rituximab specifically reduces the production of thyroid stimulating antibodies - El Fassi, D; Banga, J P; Gilbert, J A; Padoa, C; Hegedüs, L; Nielsen, C H (Clin Immunol, 2009)